pentetic acid has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbeau, A; Poirier, J | 1 |
| Heinecke, JW; Jackson-Lewis, V; Pennathur, S; Przedborski, S | 1 |
2 other study(ies) available for pentetic acid and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
MPTP potentiates iron-induced lipid peroxidation without the involvement of free radicals derived from oxygen.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Cytochrome c Group; Erythrocytes; Humans; Hydrogen Peroxide; In Vitro Techniques; Iron; Lipid Peroxides; Malondialdehyde; Pentetic Acid; Pyridines | 1987 |
Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Brain; Chelating Agents; Dopamine Agents; Free Radicals; Gas Chromatography-Mass Spectrometry; Male; Mice; Mice, Inbred C57BL; Nitrates; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Pentetic Acid; Tissue Distribution; Tyrosine | 1999 |